Revolution Medicines, Inc.
NASDAQ:RVMD
40.5 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 543.064 | 696.148 | 161.412 | 108.497 | 104.268 | 16.659 | 69.586 | 9.079 |
| Short Term Investments
| 1,746.235 | 1,156.807 | 483.531 | 468.557 | 336.473 | 106.099 | 0 | 0 |
| Cash and Short Term Investments
| 2,289.299 | 1,852.955 | 644.943 | 577.054 | 440.741 | 122.758 | 69.586 | 9.079 |
| Net Receivables
| 0 | 1.254 | 4.673 | 5.929 | 6.393 | 8.737 | 7.303 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 6.597 | 0 |
| Other Current Assets
| 38.333 | 25.072 | 10.569 | 6.79 | 6.988 | 2.486 | 8.542 | 0.362 |
| Total Current Assets
| 2,327.632 | 1,879.281 | 660.185 | 589.773 | 454.122 | 133.981 | 85.431 | 9.441 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 141.823 | 100.014 | 73.736 | 71.236 | 36.337 | 7.147 | 6.872 | 5.253 |
| Goodwill
| 14.608 | 14.608 | 14.608 | 14.608 | 14.608 | 14.608 | 14.608 | 0 |
| Intangible Assets
| 56.67 | 57.739 | 58.807 | 59.876 | 60.945 | 62.013 | 63.082 | 0 |
| Goodwill and Intangible Assets
| 71.278 | 72.347 | 73.415 | 74.484 | 75.553 | 76.621 | 77.69 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 17.568 | 10.063 | 4.594 | 2.495 | 1.389 | 2.78 | 0.593 | 0.383 |
| Total Non-Current Assets
| 230.669 | 182.424 | 151.745 | 148.215 | 113.279 | 86.548 | 85.155 | 5.636 |
| Total Assets
| 2,558.301 | 2,061.705 | 811.93 | 737.988 | 567.401 | 220.529 | 170.586 | 15.077 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 54.427 | 61.788 | 21.306 | 14.057 | 12.609 | 11.4 | 5.236 | 3.353 |
| Short Term Debt
| 12.872 | 7.369 | 6.773 | 6.214 | 3.672 | 0.2 | 0.147 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 4.459 | 12.358 | 12.111 | 17.124 | 16.83 | 0 |
| Other Current Liabilities
| 96.615 | 74.694 | 29.446 | 27.721 | 18.784 | 14.528 | 8.339 | 4.245 |
| Total Current Liabilities
| 163.914 | 143.851 | 61.984 | 60.35 | 47.176 | 43.052 | 30.552 | 7.598 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 122.971 | 80.575 | 57.432 | 60.419 | 28.992 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 6.573 | 8.481 | 14.727 | 28.413 | 0 |
| Deferred Tax Liabilities Non-Current
| 2.353 | 3.115 | 7.025 | 7.444 | 7.444 | 7.819 | 12.192 | 0 |
| Other Non-Current Liabilities
| 3.859 | 7.97 | 0.301 | 0.634 | 0.632 | 2.396 | 2.77 | 2.948 |
| Total Non-Current Liabilities
| 129.183 | 91.66 | 64.758 | 75.07 | 45.549 | 24.942 | 43.375 | 2.948 |
| Total Liabilities
| 293.097 | 235.511 | 126.742 | 135.42 | 92.725 | 67.994 | 73.927 | 10.546 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 305.109 | 205.081 | 72.248 |
| Common Stock
| 0.018 | 0.016 | 0.009 | 0.008 | 0.007 | 0 | 0 | 0 |
| Retained Earnings
| -1,737.801 | -1,137.708 | -701.341 | -452.636 | -265.545 | -157.386 | -109.722 | -67.933 |
| Accumulated Other Comprehensive Income/Loss
| 1.321 | 0.544 | -1.78 | -0.376 | 0.116 | 0.074 | 0 | 0 |
| Other Total Stockholders Equity
| 4,001.666 | 2,963.342 | 1,388.3 | 1,055.572 | 740.098 | 4.738 | 1.3 | 0.216 |
| Total Shareholders Equity
| 2,265.204 | 1,826.194 | 685.188 | 602.568 | 474.676 | 152.535 | 96.659 | 4.531 |
| Total Equity
| 2,265.204 | 1,826.194 | 685.188 | 602.568 | 474.676 | 152.535 | 96.659 | 4.531 |
| Total Liabilities & Shareholders Equity
| 2,558.301 | 2,061.705 | 811.93 | 737.988 | 567.401 | 220.529 | 170.586 | 15.077 |